БЛОГ

Archive for the ‘health’ category: Page 103

Jul 9, 2022

New study shows staggering effect of coronavirus pandemic on America’s mental health

Posted by in categories: biotech/medical, health, neuroscience

When the novel coronavirus roared into the U.S., mental health took a back seat to physical health. The number one priority was making sure hospitals wouldn’t be overwhelmed and that as many lives as possible could be saved.

Schools closed, remote work became the norm, restaurants shuttered and getting together with friends was no longer possible. The news cycle spun with story after story highlighting the ever-increasing number of cases and deaths, while unemployment soared to levels not seen since the Great Depression.

Any one of these shifts could be expected to cause an increase in issues. Put together, they created a a perfect storm for a crisis.

Jul 9, 2022

The omicron subvariant now dominating the US is ‘the worst version of the virus that we’ve seen’

Posted by in categories: biotech/medical, health

New immune-evading Omicron subvariant BA.5 is now dominant in the U.S.—and previous heavy hitter “stealth Omicron” is now a shadow of its former self, according to federal health data released Tuesday.

BA.5 is estimated to have caused nearly 54% of COVID infections in the U.S. last week, according to data from the U.S. Centers for Disease Control and Prevention. Along with twin variant BA.4, it swept South Africa this spring thanks to its ability to evade immunity from both prior infection and vaccination.

The week before that, the two variants combined made up slightly more than half of U.S. cases. But last week, BA.5 accomplished the same feat alone, without the help of BA.4, which came in third at 16.5%.

Jul 8, 2022

New gene profiling technology reveals melanoma biomarkers

Posted by in categories: biotech/medical, evolution, health

A new UC Davis-led study sheds light on cell type-specific biomarkers, or signs, of melanoma. The research was recently published in the Journal of Investigative Dermatology.

Melanoma, the deadliest of the common skin cancers, is curable with and treatment. However, diagnosing clinically and under the microscope can be complicated by what are called melanocytic nevi—otherwise known as birth marks or moles that are non-cancerous. The development of melanoma is a multi-step process where “melanocytes,” or the cells in the skin that contain melanin, mutate and proliferate. Properly identifying melanoma at an early stage is critical for improved survival.

“The biomarkers of early melanoma evolution and their origin within the tumor and its microenvironment are a potential key to early diagnosis of melanoma,” said corresponding author of the study Maija Kiuru, associate professor of clinical dermatology and pathology at UC Davis Health. “To unravel the mystery, we used high-plex spatial RNA profiling to capture distinct gene expression patterns across cell types during melanoma development. This approach allows studying the expression of hundreds or thousands of genes without disrupting the native architecture of the tumor.”

Jul 8, 2022

Graphene tattoo provides cuffless blood pressure monitoring

Posted by in categories: biotech/medical, health

Near-invisible graphene tattoos deliver high-speed and long-term continuous monitoring of blood pressure with high accuracy.


Wrapping a cuff around a patient’s arm and inflating it to measure blood pressure is one of the most routinely performed medical tests. It provides a quick and reliable assessment of cardiovascular health, as blood pressure is an independent predictor of all-cause mortality. But such arm cuffs are bulky and uncomfortable, making them impractical for continuous monitoring outside of clinics.

For this reason, researchers are developing cuffless alternatives with the goal of unlocking new possibilities for patient diagnostics and management, as well as providing new understanding of physiology. However, none of these tools has become a mainstay yet.

Continue reading “Graphene tattoo provides cuffless blood pressure monitoring” »

Jul 7, 2022

Chinese researchers develop AI that can read minds and determine party loyalty, report reveals

Posted by in categories: health, robotics/AI

Chinese researchers have reportedly developed artificial intelligence (AI) that can read the minds of Chinese Communist Party (CCP) officials.

A video report detailed the software’s features and attributed it to the Hefei Comprehensive National Science Center, a relatively new institute focused on health and environment, energy research, information management and artificial intelligence.

The technology essentially tests one’s level of loyalty to the CCP. According to the center, it would “further solidify their [members’] confidence and determination to be grateful to the party, listen to the party and follow the party.”

Jul 3, 2022

Jennifer Doudna | Four ways that CRISPR will revolutionize healthcare

Posted by in categories: bioengineering, biotech/medical, chemistry, food, health, policy

Hear from Nobel laureate Jennifer Doudna on the four ways that CRISPR gene editing technologies will revolutionize healthcare.

In her 31 March talk at the Frontiers Forum, Prof Jennifer Doudna outlined how CRISPR-based therapies are already transforming the lives of patients with previously limited treatment options. She also gave her vision for how her serendipitous discovery will revolutionize healthcare for us all. The session was attended by over 9,200 representatives from science, policy and business across the world.

Continue reading “Jennifer Doudna | Four ways that CRISPR will revolutionize healthcare” »

Jul 2, 2022

A model that allows robots to follow and guide humans in crowded environments

Posted by in categories: health, robotics/AI, transportation

Assistance robots are typically mobile robots designed to assist humans in malls, airports, health care facilities, home environments and various other settings. Among other things, these robots could help users to find their way around unknown environments, for instance guiding them to a specific location or sharing important information with them.

While the capabilities of assistance robots have improved significantly over the past decade, the systems that have so far been implemented in real-world environments are not yet capable of following or guiding humans efficiently within crowded spaces. In fact, training robots to track a specific user while navigating a dynamic environment characterized by many randomly moving “obstacles” is far from a simple task.

Researchers at the Berlin Institute of Technology have recently introduced a new model based on deep reinforcement learning that could allow to guide a specific user to a desired location or follow him/her around while carrying their belongings, all within a crowded environment. This model, introduced in a paper pre-published on arXiv, could help to significantly enhance the capabilities of robots in malls, airports and other public places.

Jul 1, 2022

Looking Beyond 2050 — On Earth and in Space with Lord Martin Rees

Posted by in categories: biotech/medical, business, education, evolution, food, health, media & arts, neuroscience

Cosmologist, noted author, Astronomer Royal and recipient of the 2015 Nierenberg Prize for Science in the Public Interest Lord Martin Rees delivers a thought-provoking and insightful perspective on the challenges humanity faces in the future beyond 2050. [3/2016] [Show ID: 30476]

Frontiers of Knowledge.
(https://www.uctv.tv/frontiers-of-knowledge)

Continue reading “Looking Beyond 2050 — On Earth and in Space with Lord Martin Rees” »

Jun 30, 2022

Mimicking the function of Ruffini receptors using a bio-inspired artificial skin

Posted by in categories: biological, cyborgs, habitats, health, robotics/AI

Mobile robots are now being introduced into a wide variety of real-world settings, including public spaces, home environments, health care facilities and offices. Many of these robots are specifically designed to interact and collaborate with humans, helping them to complete hands-on physical tasks.

To improve the performance of on interactive and manual tasks, roboticists will need to ensure that they can effectively sense stimuli in their environment. In recent years, many engineers and material scientists have thus been trying to develop systems that can artificially replicate biological sensory processes.

Researchers at Scuola Superiore Sant’Anna, Ca’ Foscari University of Venice, Sapienza University of Rome and other institutes in Italy have recently used an artificial skin and a that could be used to improve the tactile capabilities of both existing and newly developed robots to replicate the function of the so-called Ruffini receptors. Their approach, introduced in a paper published in Nature Machine Intelligence, replicates the function of a class of cells located on the human superficial dermis (i.e., subcutaneous skin tissue), known as Ruffini receptors.

Jun 30, 2022

New health research suggests novel combination therapy for triple-negative breast cancer

Posted by in categories: augmented reality, biotech/medical, health

Research led by Suresh Alahari, Ph.D., Professor of Biochemistry at LSU Health New Orleans schools of Medicine and Graduate Studies, suggests a combination of drugs already approved by the FDA for other cancers may be effective in treating chemo-resistant triple-negative breast cancer. The results are published in Molecular Cancer.

Triple-negative breast cancer (TNBC) tumors lack estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). A subtype representing 12–55% of tumors has androgen receptors (AR). Since stimulate tumor cell progression in estrogen receptor-negative breast cancers, they have become a target of triple-negative breast cancer therapy. As well, since a substantial number of patients with triple-negative breast cancer develop resistance to paclitaxel, the FDA-approved chemotherapeutic agent for triple-negative breast cancer, new therapeutic approaches are needed.

Working in a mouse model and tissue from patients with triple-negative breast cancer, the research team screened 133 FDA-approved drugs that have a therapeutic effect against androgen receptor cells. They found that ceritinib, an FDA-approved drug for lung cancers, efficiently inhibited the growth of androgen receptor triple-negative breast cancer cells. To improve the response, they also selected enzalutamide, an FDA-approved androgen receptor antagonist for prostate cancer treatment.